Quest Diagnostics Inc Increase (Decrease) in Accounts Receivable
Quest Diagnostics Inc (DGX) reported Increase (Decrease) in Accounts Receivable of $259.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-23
- Quest Diagnostics Inc increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $79.00M, a 464.29% increase year-over-year.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $180.00M, a 78.22% increase year-over-year.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$47.00M.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $38.00M, a 40.74% increase year-over-year.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for fiscal 2025 was $106.00M, a 49.30% increase from fiscal 2024.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for fiscal 2024 was $71.00M, a 373.33% increase from fiscal 2023.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for fiscal 2023 was $15.00M.
- Quest Diagnostics Inc increase (decrease) in accounts receivable for fiscal 2022 was -$246.00M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $259.00M 10-Q · filed 2026-07-23 | $212.00M derived: sum of 3 quarters · filed 2026-07-23 | $250.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | $180.00M 10-Q · filed 2026-04-22 | $133.00M derived: sum of 2 quarters · filed 2026-04-22 | $171.00M derived: sum of 3 quarters · filed 2026-04-22 | $185.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | -$47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.00M derived: sum of 2 quarters · filed 2026-02-26 | $5.00M derived: sum of 3 quarters · filed 2026-07-23 | $106.00M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $52.00M derived: sum of 2 quarters · filed 2026-07-23 | $153.00M 10-Q · filed 2025-10-21 | $84.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $115.00M 10-Q · filed 2026-07-23 | $46.00M derived: sum of 3 quarters · filed 2026-07-23 | $73.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | $101.00M 10-Q · filed 2026-04-22 | $32.00M derived: sum of 2 quarters · filed 2026-04-22 | $59.00M derived: sum of 3 quarters · filed 2026-04-22 | $58.00M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-31 | -$69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$42.00M derived: sum of 2 quarters · filed 2026-02-26 | -$43.00M derived: sum of 3 quarters · filed 2026-02-26 | $71.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $26.00M derived: sum of 2 quarters · filed 2025-10-21 | $140.00M 10-Q · filed 2025-10-21 | $69.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $113.00M 10-Q · filed 2025-07-23 | $42.00M derived: sum of 3 quarters · filed 2026-02-26 | $90.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $114.00M 10-Q · filed 2025-04-23 | $43.00M derived: sum of 2 quarters · filed 2026-02-26 | $91.00M derived: sum of 3 quarters · filed 2026-02-26 | $71.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$23.00M derived: sum of 2 quarters · filed 2026-02-26 | -$43.00M derived: sum of 3 quarters · filed 2026-02-26 | $15.00M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | $28.00M derived: sum of 2 quarters · filed 2024-10-23 | $86.00M 10-Q · filed 2024-10-23 | $2.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | -$20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $38.00M 10-Q · filed 2024-07-24 | -$46.00M derived: sum of 3 quarters · filed 2025-02-20 | -$58.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $58.00M 10-Q · filed 2024-04-24 | -$26.00M derived: sum of 2 quarters · filed 2025-02-20 | -$38.00M derived: sum of 3 quarters · filed 2025-02-20 | -$116.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | -$84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$96.00M derived: sum of 2 quarters · filed 2025-02-20 | -$174.00M derived: sum of 3 quarters · filed 2025-02-20 | -$246.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$90.00M derived: sum of 2 quarters · filed 2023-10-25 | -$162.00M 10-Q · filed 2023-10-25 | -$198.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | -$78.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$150.00M 10-Q · filed 2023-07-27 | -$186.00M derived: sum of 3 quarters · filed 2024-02-22 | $34.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$72.00M 10-Q · filed 2023-04-28 | -$108.00M derived: sum of 2 quarters · filed 2024-02-22 | $112.00M derived: sum of 3 quarters · filed 2024-02-22 | -$15.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $184.00M derived: sum of 2 quarters · filed 2024-02-22 | $57.00M derived: sum of 3 quarters · filed 2024-02-22 | -$81.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $220.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $93.00M derived: sum of 2 quarters · filed 2022-10-21 | -$45.00M 10-Q · filed 2022-10-21 | $55.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | -$127.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | -$265.00M 10-Q · filed 2022-07-22 | -$165.00M derived: sum of 3 quarters · filed 2023-02-21 | $115.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | -$138.00M 10-Q · filed 2022-04-22 | -$38.00M derived: sum of 2 quarters · filed 2023-02-21 | $242.00M derived: sum of 3 quarters · filed 2023-02-21 | $402.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $380.00M derived: sum of 2 quarters · filed 2023-02-21 | $540.00M derived: sum of 3 quarters · filed 2023-02-21 | $455.00M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $280.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $440.00M derived: sum of 2 quarters · filed 2021-10-22 | $355.00M 10-Q · filed 2021-10-22 | $305.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $160.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-23 | $75.00M 10-Q · filed 2021-07-23 | $25.00M derived: sum of 3 quarters · filed 2022-02-28 | $57.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$85.00M 10-Q · filed 2021-04-23 | -$135.00M derived: sum of 2 quarters · filed 2022-02-28 | -$103.00M derived: sum of 3 quarters · filed 2022-02-28 | -$93.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$18.00M derived: sum of 2 quarters · filed 2022-02-28 | -$8.00M derived: sum of 3 quarters · filed 2022-02-28 | $63.00M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $32.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $42.00M derived: sum of 2 quarters · filed 2020-10-23 | $113.00M 10-Q · filed 2020-10-23 | $12.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $81.00M 10-Q · filed 2020-07-24 | -$20.00M derived: sum of 3 quarters · filed 2021-02-22 | $19.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $71.00M 10-Q · filed 2020-05-04 | -$30.00M derived: sum of 2 quarters · filed 2021-02-22 | $9.00M derived: sum of 3 quarters · filed 2021-02-22 | $39.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | -$101.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$62.00M derived: sum of 2 quarters · filed 2021-02-22 | -$32.00M derived: sum of 3 quarters · filed 2021-02-22 | $65.00M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $69.00M derived: sum of 2 quarters · filed 2019-10-23 | $166.00M 10-Q · filed 2019-10-23 | $128.00M derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-06-30 | $30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $127.00M 10-Q · filed 2019-07-24 | $89.00M derived: sum of 3 quarters · filed 2020-02-20 | $94.00M derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-03-31 | $97.00M 10-Q · filed 2019-04-24 | $59.00M derived: sum of 2 quarters · filed 2020-02-20 | $64.00M derived: sum of 3 quarters · filed 2020-02-20 | $53.00M derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2017-12-31 | -$38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$33.00M derived: sum of 2 quarters · filed 2020-02-20 | -$44.00M derived: sum of 3 quarters · filed 2020-02-20 | -$9.00M 10-K · filed 2020-02-20 | $298.00M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24 | -$6.00M derived: sum of 2 quarters · filed 2018-10-24 | $29.00M 10-Q · filed 2018-10-24 | $265.00M 10-Q · filed 2017-10-19 | -$245.00M derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2017-06-30 | -$11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $24.00M 10-Q · filed 2018-07-25 | $185.00M 10-Q · filed 2017-07-25 | -$250.00M derived: sum of 3 quarters · filed 2019-02-21 | -$183.00M derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2017-03-31 | $35.00M 10-Q · filed 2018-04-20 | $117.00M 10-Q · filed 2017-04-21 | -$239.00M derived: sum of 2 quarters · filed 2019-02-21 | -$172.00M derived: sum of 3 quarters · filed 2019-02-21 | -$68.00M derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2016-12-31 | -$274.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$207.00M derived: sum of 2 quarters · filed 2019-02-21 | -$103.00M derived: sum of 3 quarters · filed 2019-02-21 | $42.00M 10-K · filed 2019-02-21 | $343.00M 10-K · filed 2017-02-22 | |||
| 2016-09-30 | $67.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $171.00M derived: sum of 2 quarters · filed 2017-10-19 | $316.00M 10-Q · filed 2017-10-19 | $364.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $104.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $249.00M 10-Q · filed 2017-07-25 | $297.00M derived: sum of 3 quarters · filed 2018-02-23 | $348.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $145.00M 10-Q · filed 2017-04-21 | $193.00M derived: sum of 2 quarters · filed 2018-02-23 | $244.00M derived: sum of 3 quarters · filed 2018-02-23 | $310.00M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $99.00M derived: sum of 2 quarters · filed 2018-02-23 | $165.00M derived: sum of 3 quarters · filed 2018-02-23 | $262.00M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $51.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-21 | $117.00M derived: sum of 2 quarters · filed 2016-10-21 | $214.00M 10-Q · filed 2016-10-21 | $266.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-25 | $163.00M 10-Q · filed 2016-07-25 | $215.00M derived: sum of 3 quarters · filed 2017-02-22 | $284.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $97.00M 10-Q · filed 2016-04-27 | $149.00M derived: sum of 2 quarters · filed 2017-02-22 | $218.00M derived: sum of 3 quarters · filed 2017-02-22 | $257.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $121.00M derived: sum of 2 quarters · filed 2017-02-22 | $160.00M derived: sum of 3 quarters · filed 2017-02-22 | $312.00M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $108.00M derived: sum of 2 quarters · filed 2015-10-29 | $260.00M 10-Q · filed 2015-10-29 | |||||
| 2014-06-30 | $39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $191.00M 10-Q · filed 2015-07-30 | ||||||
| 2014-03-31 | $152.00M 10-Q · filed 2015-04-30 | |||||||
| 2013-12-31 | $247.00M 10-K · filed 2016-02-26 | |||||||
| 2012-12-31 | $243.00M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |